Date: September 2, 2025
Attention: All Providers
Effective date: August 27, 2025
Call to action: Texas Children’s Health Plan (TCHP) would like inform providers that effective August 27, 2025, Unichem Pharmaceuticals (USA), Inc. voluntarily recalled one (1) lot of Cyclobenzaprine Hydrochloride Tablets USP 10 mg to the consumer level. The Cyclobenzaprine 10 mg (90-count) label was inadvertently placed on bottles containing Meloxicam 7.5 mg tablets.
Product affected:
| Impacted Medication | NDC No. | Lot No. | Expiration Date |
| CYCLOBENZAPRINE HYDROCHLORIDE TABELTS USP 10 MG | 29300-415-19 | GMML24026A | Sept 2027 |
How this impacts providers: This recall may affect providers whose patients were dispensed the impacted lot, as members may unknowingly be taking Meloxicam instead of Cyclobenzaprine. This could result in ineffective therapy for muscle spasms as well as the potential for adverse effects associated with unintended NSAID use. Providers should be aware that affected patients may contact their offices with questions or concerns and may need counseling regarding discontinuation of the recalled product and appropriate replacement therapy.
Next step for providers: Providers should inform their impacted patients and arrange for the return and replacement of the drug.
If you have any questions, please email TCHP Pharmacy at: providerrelations@texaschildrens.org
For access to all provider alerts,log into:
www.texaschildrenshealthplan.org/provideralerts.